Many providers are contemplating giving their staff members antibody (Ab) screening for SARS-CoV-2, the virus that results in COVID-19. Although businesses want staff members to be self-assured about returning to perform, and the federal government wishes better estimates of an infection costs, there are even now quite a few questions about the value, dependability and usefulness of the screening.
More Stories
Navigating Contracts: Essential Tips for Business Owners
The Role of Compliance in Business and Law
Emerging Legal Issues in the Business World